- Home
- SGN vs ADIL Comparison
SGN vs ADIL Comparison
Compare SGN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGN
- ADIL
- Stock Information
- Founded
- SGN 2019
- ADIL 2010
- Country
- SGN United States
- ADIL United States
- Employees
- SGN N/A
- ADIL N/A
- Industry
- SGN
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- SGN
- ADIL Health Care
- Exchange
- SGN Nasdaq
- ADIL Nasdaq
- Market Cap
- SGN 7.8M
- ADIL 7.7M
- IPO Year
- SGN 2023
- ADIL 2018
- Fundamental
- Price
- SGN $1.19
- ADIL $0.32
- Analyst Decision
- SGN
- ADIL Strong Buy
- Analyst Count
- SGN 0
- ADIL 1
- Target Price
- SGN N/A
- ADIL $1.50
- AVG Volume (30 Days)
- SGN 89.7K
- ADIL 420.1K
- Earning Date
- SGN 11-12-2025
- ADIL 11-13-2025
- Dividend Yield
- SGN N/A
- ADIL N/A
- EPS Growth
- SGN N/A
- ADIL N/A
- EPS
- SGN N/A
- ADIL N/A
- Revenue
- SGN $366,344.00
- ADIL N/A
- Revenue This Year
- SGN N/A
- ADIL N/A
- Revenue Next Year
- SGN N/A
- ADIL N/A
- P/E Ratio
- SGN N/A
- ADIL N/A
- Revenue Growth
- SGN N/A
- ADIL N/A
- 52 Week Low
- SGN $0.44
- ADIL $0.22
- 52 Week High
- SGN $8.60
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- SGN 35.75
- ADIL 44.42
- Support Level
- SGN $1.15
- ADIL $0.28
- Resistance Level
- SGN $1.61
- ADIL $0.33
- Average True Range (ATR)
- SGN 0.11
- ADIL 0.02
- MACD
- SGN -0.01
- ADIL -0.00
- Stochastic Oscillator
- SGN 9.64
- ADIL 52.84
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.